References
Roach E, Gomez M, Northrup H (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13(12):624–628
Rakowski SK, Winterkorn EB, Paul E, Steele DJR, Halpern EF, Thiele EA (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70(10):1777–1782
Schillinger F, Montagnac R (1996) Chronic renal failure and its treatment in tuberous sclerosis. Nephrol Dial Transplant 11(3):481–485
Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM et al (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease—a contiguous gene syndrome. Nat Genet 8(4):328–332
Sampson JR, Maheshwar MM, Aspinwall R, Thompson P, Cheadle JP, Ravine D et al (1997) Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61(4):843–851
Tarasewicz A, Dȩbska-Ślizień A, Konopa J, Zdrojewski Z, Rutkowski B (2009) Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex. Transplant Proc 41(9):3677–3682
Acknowledgments
The genetic test was funded by grant NMRC/PPG/KKH12010-Theme3 from the National Medical Research Council, Ministry of Health, Republic of Singapore.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, C.C., Tan, H., Thangaraju, S. et al. End-stage renal disease in tuberous sclerosis complex-polycystic kidney disease contiguous gene syndrome: epidemiology, clinical manifestations and implications for transplantation. Int Urol Nephrol 46, 1869–1870 (2014). https://doi.org/10.1007/s11255-014-0735-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0735-9